Which is better: Oncotype DX or MammaPrint for breast cancer?

Hi Sagar. Here is a webinar we did on the topic that you might find helpful. 💛 Suzanne (Community Moderator) https://outcomes4me.com/article/exploring-tests-for-breast-cancer-patients-oncotype-dx-and-beyond/

Outcomes4Me

Exploring tests for breast cancer patients: Oncotype DX and beyond

Dr. Sara Hurvitz explores how tests including Oncotype DX, MammaPrint, Breast Cancer Index, & more can support breast cancer patients.

I like knowing that I have luminal B from the mammoprint.

Both Oncotype DX and MammaPrint are valuable genomic tests that help guide treatment decisions for HR+ HER2- breast cancer, and each has its own strengths in predicting recurrence risk and chemotherapy benefit. The best choice often depends on individual factors like tumor characteristics, lymph node status, and specific clinical situation, so discussing the pros and cons of each test with your oncology team can help determine which might be most informative for your particular case.